Bausch Health Files 8-K: Corporate Updates

Ticker: BHC · Form: 8-K · Filed: Jun 18, 2025 · CIK: 885590

Sentiment: neutral

Topics: corporate-filing, 8-K

TL;DR

Bausch Health filed an 8-K on 6/18/25. Nothing major, just corporate housekeeping.

AI Summary

Bausch Health Companies Inc. filed an 8-K on June 18, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing indicates the company's principal executive offices are located at 2150 St. Elzear Blvd. West, Laval, Quebec, Canada. The company was formerly known as Valeant Pharmaceuticals International, Inc. and Bio Vail Corp.

Why It Matters

This 8-K filing provides an update on Bausch Health's corporate structure and reporting, which is important for investors to stay informed about the company's official disclosures.

Risk Assessment

Risk Level: low — The filing appears to be routine corporate reporting and does not indicate any significant new risks or material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Bausch Health Companies Inc.?

The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of June 18, 2025.

Where are Bausch Health Companies Inc.'s principal executive offices located?

Bausch Health Companies Inc.'s principal executive offices are located at 2150 St. Elzear Blvd. West, Laval, Quebec, Canada.

What were some of the former names of Bausch Health Companies Inc.?

Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.

What is the SEC Act under which this 8-K is filed?

This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the Commission File Number for Bausch Health Companies Inc.?

The Commission File Number for Bausch Health Companies Inc. is 001-14956.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Bausch Health Companies Inc. (BHC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing